NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NAUT

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/30	21 : 00	GlobeNewswire Inc.	Nautilus Biotechnology Reports First Quarter 2024 Financial Results	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/04/11	21 : 00	GlobeNewswire Inc.	Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/07	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/07	06 : 39	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/06	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/06	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/06	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/06	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/03/06	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	22 : 00	GlobeNewswire Inc.	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	21 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	21 : 25	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	21 : 15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	21 : 04	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/28	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/22	22 : 00	GlobeNewswire Inc.	Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference	NASDAQ:NAUT	Nautilus Biotechnology Inc
2024/02/07	22 : 00	GlobeNewswire Inc.	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/12/15	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/11/30	22 : 00	GlobeNewswire Inc.	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/11/01	21 : 05	GlobeNewswire Inc.	Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/11/01	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/10/31	21 : 05	GlobeNewswire Inc.	Nautilus Biotechnology Reports Third Quarter 2023 Financial Results	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/10/11	21 : 05	GlobeNewswire Inc.	Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/09/06	20 : 30	GlobeNewswire Inc.	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/08/04	21 : 00	GlobeNewswire Inc.	Nautilus Biotechnology to Participate in Upcoming August Investor Conferences	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/08/03	05 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/08/02	20 : 30	GlobeNewswire Inc.	Nautilus Biotechnology Reports Second Quarter 2023 Financial Results	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/07/11	22 : 23	GlobeNewswire Inc.	Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/06/21	19 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NAUT	Nautilus Biotechnology Inc
2023/06/17	08 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:NAUT	Nautilus Biotechnology Inc